In early December, VMT-α-NET, the Company’s lead drug for the treatment of neuroendocrine tumors was administered to patients in India on a compassionate use basis, independent of a planned US trial…
In early December, VMT-α-NET, the Company’s lead drug for the treatment of neuroendocrine tumors was administered to patients in India on a compassionate use basis, independent of a planned US trial…
Always strive for better work. Never stop learning. Have fun a clear plan for a new project or just an idea on a napkin? Sky, land, and sea disappear together out of the world…
